Drip-Feeding: How the Pharmaceutical Industry Influences Research Ethics Committees

Research Ethics 3 (4):113-117 (2007)
  Copy   BIBTEX

Abstract

Whilst research ethics committees exist to represent society's interests by placing appropriate checks on the economic power of ‘big pharma’, the political sphere is here seen to have generally acquiesced to economic interests and allowed industry to influence how it is regulated. RECs are accordingly urged to remain vigilant about the prospects of their being the subject of hidden influences.

Categories

Keywords

Reprint years

DOI

10.1177/174701610700300403

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,283

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Manual for research ethics committees.Sue Eckstein (ed.) - 2003 - New York: Cambridge University Press.
Understanding physician-pharmaceutical industry interactions.Shaili Jain - 2007 - New York: Cambridge University Press.
Researchers and subpoenas: the troubling precedent of the Selikoff case.Angela R. Holder - 1988 - IRB: Ethics & Human Research 11 (6):8-10.
How Pharmaceutical Industry Employees Manage Competing Commitments in the Face of Public Criticism.Wendy Lipworth, Kathleen Montgomery & Miles Little - 2013 - Journal of Bioethical Inquiry 10 (3):355-367.
The connection between academia and industry.Ajai Singh & Shakuntala Singh - 2005 - Mens Sana Monographs 3 (1):5.
Medicine and pharmacy — facts and myths about the development of an innovative pharmaceutical industry in Poland.Włodzimierz Kubiak - 2005 - Science and Engineering Ethics 11 (1):41-51.
Ethics Committee or Community? examining the identity of Czech Ethics Committees in the period of transition.J. Simek, L. Zamykalova & M. Mesanyova - 2010 - Journal of Medical Ethics 36 (9):548-552.
Pharmaceutical medicine.D. M. Burley & Theodore Barker Binns (eds.) - 1985 - Baltimore, Md., U.S.A.: E. Arnold.
Compensation for subjects of medical research: the moral rights of patients and the power of research ethics committees.S. Guest - 1997 - Journal of Medical Ethics 23 (3):181-185.
Moral Psychology and the Intuition that Pharmaceutical Companies Have a ‘Special’ Obligation to Society.James M. Huebner - 2014 - Journal of Buisness Ethics (3):1-10.
Dangerous Medicine: The Pharmaceutical Industry's Questionable Ethical Practices.John T. Fielding - unknown
Research ethics committees at work: the experience of one multi-location study.A. E. While - 1996 - Journal of Medical Ethics 22 (6):352-355.
Research ethics committees: the role of ethics in a regulatory authority.S. McGuinness - 2008 - Journal of Medical Ethics 34 (9):695-700.
The ethics of the pharmaceutical industry and the need for a dual market system.Anna Kreiner - 1995 - Journal of Medical Humanities 16 (1):55-68.

Analytics

Added to PP
2014-01-21

Downloads
5 (#1,544,856)

6 months
2 (#1,206,802)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Should research ethics committees be told how to think?G. M. Sayers - 2007 - Journal of Medical Ethics 33 (1):39-42.
Problems with Codes.Roger Homan - 2006 - Research Ethics 2 (3):98-103.

Add more references